Reuters logo
BRIEF-Interpace Diagnostics reports Q2 ‍loss per share from cont ops of $0.65
August 10, 2017 / 3:20 PM / 4 months ago

BRIEF-Interpace Diagnostics reports Q2 ‍loss per share from cont ops of $0.65

Aug 10 (Reuters) - Interpace Diagnostics Group Inc:

* Interpace Diagnostics Group reports second quarter 2017 financial results, business progress and recent accomplishments

* Qtrly ‍loss per share from continuing operations​ $0.65

* Qtrly revenue $3.9 million versus $3.6 million​‍​

* Qtrly net loss per diluted share of common stock $0.65​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below